Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetranectin-targeting monoclonal antibodies to fight against lethal sepsis and other pathologies

Tetranectin-targeting monoclonal antibodies to fight against lethal sepsis and other pathologies

US Patent 12497446 · Granted Dec 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fluorovinylbenzamide compound as PD-L1 immunomodulator2025
Fused-cyclic pyrazolone formamide compound and preparation method therefor, phar2025
Compound as highly selective ROS1 inhibitor and use thereof2025
Tape dispenser2025
Nerve stimulation for treatment of diseases and disorders2025
Pyrrolotriazine compounds acting as MNK inhibitor2025
System and method for zero-voltage detection in resonant pole inverters2025
Chandelier2025
Compound for use in retinal diseases2025
Crystalline form of ATR inhibitor and use thereof2025
Anti-cutting hand device for tape dispenser2025
Crystal form of pyridinylphenyl compound and preparation method therefor2025